Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model

Journal of Surgical Research

Volumn 189, Issue 1, 2014, Pages 106-116

  Tsai, Yin Tzu ^a   Wang, Che Chuan ^b,c,d   Leung, Pak On ^a   Lin, Kao Chang ^a,d   Chio, Chung Ching ^b   Hu, Chiao Ya ^a   Kuo, Jinn Rung ^a,b,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Department of Neurosurgery ^*  (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Cell apoptosis; Extracellular signal regulated kinases (ERK1 2); Fluid percussion injury; Infarction volume; Maximal angle; Tamoxifen

Indexed keywords

ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; FLUID PERCUSSION INJURY; MALE; MOTOR DYSFUNCTION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

CELL APOPTOSIS; EXTRACELLULAR SIGNAL-REGULATED KINASES (ERK1/2); FLUID PERCUSSION INJURY; INFARCTION VOLUME; MAXIMAL ANGLE; TAMOXIFEN;

ANIMALS; APOPTOSIS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOTOR NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84898834627     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.02.009     Document Type: Article

References (54)

1. L.F. Marshall Epidemiology and cost of central nervous system injury Clin Neurosurg 46 2000 105
2. D.J. Thurman The epidemiology and economics of head trauma L. Miller, R. Hayes, Head Trauma Therapeutics: Basic, Preclinical and Clinical Aspects 2001 Wiley New York
3. J. Nortje, and D.K. Menon Traumatic brain injury: physiology, mechanism and outcome Curr Opin Neurol 17 2004 711
4. I. Ng, T.T. Yeo, W.Y. Tang, R. Soong, P.Y. Ng, and D.R. Smith Apoptosis occurs after cerebral contusions in humans Neurosurgery 46 2000 949
5. F.M. Smith, R. Raghupathi, and M.A. MacKinnon et al. TUNEL-positive staining of surface contusions after fatal head injury in man Acta Neuropathol 100 2000 537
6. L. Zhao, K. O'Neill, and R. Diaz Brinton Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs Brain Res Brain Res Rev 49 2005 472
7. T. Jover-Mengual, R.S. Zukin, and A.M. Etgen MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia Endocrinology 148 2007 1131
8. L. Zhao, and R.D. Brinton Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons Brain Res 1172 2007 48
9. L.L. DonCarlos, and L. Azcoitia Neuroprotective actions of selective estrogen receptor modulators Psychoneuroendocrinology 34 2009 S113
10. V.C. Jordan, and S. Koerner Tamoxifen (ICI 46,474) and the human carcinoma 8S estrogen receptor Eur J Cancer 11 1975 205
11. A. Biegon, M. Brewster, H. Degani, E. Pop, D. Somjen, and A.M. Kaye A permanently charged TAM derivative displays anticancer activity and improved tissue selectivity in rodents Cancer Res 56 1996 4328
12. E.A. Lien, K. Wester, P.E. Lonning, E. Solheim, and P.M. Ueland Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients Br J Cancer 63 1991 641
13. H.J. Grill, and K. Pollow Pharmacokinetics of droloxifene and its metabolites in breast cancer patients Am J Clin Oncol 14 1991 S21
14. D.S. Tian, J.L. Liu, M.J. Xie, Y. Zhan, and W.S. Qu Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats J Neurochem 109 2009 1658
15. C. Wakade, M.M. Khan, L.M. De Sevilla, Q.G. Zhang, V.B. Mahesh, and D.W. Brann Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase Endocrinology 149 2008 367
16. H.K. Kimelberg, Y. Jin, C. Charniga, and P.J. Feustel Neuroprotective activity of tamoxifen in permanent focal ischemia J Neurosurg 99 2003 138
17. S.H. Mehta, K.M. Dhandapani, L.M. De Sevilla, R.C. Webb, V.B. Mahesh, and D.W. Brann Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat Neuroendocrinology 77 2003 44
18. J.L. Liu, D.S. Tian, Z.W. Li, W.S. Qu, and Y. Zhan Tamoxifen alleviates irradiation-induced brain injury by attenuating microglial inflammatory response in vitro and in vivo Brain Res 1316 2010 101
19. M. Bourque, B. Liu, D.E. Dluzen, and T. Di Paolo Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity Biochem Pharmacol 74 2007 1413
20. K. Sharma, and R.D. Mehra Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax Brain Res 1204 2008 1
21. P.A. Scherle, W. Ma, H. Lim, S.K. Dey, and J.M. Trzaskos Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy J Biol Chem 275 2000 37086
22. C.M. Atkins, J.C. Selcher, J.J. Petraitis, J.M. Trzaskos, and J.D. Sweatt The MAPK cascade is required for mammalian associative learning Nat Neurosci 1 1998 602
23. T.K. Mclntosh, R. Vink, and L. Noble et al. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model Neuroscience 28 1989 233
24. Y. Wang, S.Z. Lin, A.L. Chiou, L.R. Williams, and B.J. Hoffer Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex J Neurosci 17 1997 4341
25. R.J. Mullen, C.R. Buck, and A.M. Smith Neu-N, a neuronal specific nuclear protein in vertebrates Development 116 1992 201
26. J.R. Kuo, C.J. Lo, K.C. Lin, M.T. Lin, and C.C. Chio Agmatine-promoted angiogenesis, neurogenesis, and inhibition of gliosis reduced traumatic brain injury in rats J Traum 71 2011 87
27. T.M. Hallam, C.L. Floyd, and M.M. Folkerts et al. Comparison of behavioral deficits and acute neuronal degeneration in rat lateral fluid percussion and weight-drop brain injury models J Neurotrauma 21 2004 521
28. J.E. Pierce, D.H. Smith, J.Q. Trojanowski, and T.K. McIntosh Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats Neuroscience 87 1998 359
29. C.C. Wang, K.C. Lin, B.S. Lin, C.C. Chio, and J.R. Kuo Resuscitation from experimental traumatic brain injury by magnolol therapy J Surg Res 184 2013 1045
30. T.J. Chuang, K.C. Lin, C.C. Chio, C.C. Wang, C.P. Chang, and J.R. Kuo Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats J Trauma Acute Care Surg 73 2012 1161
31. J.R. Kuo, C.J. Lo, C.P. Chang, M.T. Lin, and C.C. Chio Agmatine-promoted angiogenesis, neurogenesis, and inhibition of gliosis-reduced traumatic brain injury in rats J Trauma 71 2011 E87
32. G. Pearson, F. Robinson, and T. Beers Gibson et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr Rev 22 2001 153
33. M. Toborek, K.W. Son, A. Pudelko, K. King-Pospisil, E. Wylegala, and A.E.R.K. Malecki 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons J Cell Biochem 100 2007 279
34. J. Shen, Y. Wu, and J.Y. Xu et al. ERK-and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD Invest Ophthalmol Vis Sci 51 2010 35
35. J.D. Troadec, M. Marien, and S. Mourlevat et al. Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons Mol Pharmacol 62 2002 1043
36. X. Wang, J.L. Martindale, and N.J. Holbrook Requirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 2000 39435
37. Y. Feng, J. Huang, Y. Ding, F. Xie, and X. Shen Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation Oncol Rep 24 2010 1561
38. D. Tang, D. Wu, and A. Hirao et al. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53 J Biol Chem 277 2002 12710
39. B.A. Ballif, and J. Blenis Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals Cell Growth Differ 12 2001 397
40. A. Bonni, A. Brunet, A.E. West, S.R. Datta, M.A. Takasu, and M.E. Greenberg Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1999 1358
41. Y. Zhang, D. Milatovic, M. Aschner, P.J. Feustel, and H.K. Kimelberg Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity Exp Neurol 204 2007 819
42. K.M. Dhandapani, and D.W. Brann Protective effects of estrogen and selective estrogen receptor modulators in the brain Biol Reprod 67 2002 1379
43. J.R. Kuo, Y.H. Cheng, Y.S. Chen, C.C. Chio, and P.W. Gean Involvement of extracellular signal regulated kinases (ERK1/2) in traumatic brain injury-induced depression in rodents J Neurotrauma 30 2013 1223
44. T. Obata Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum Toxicology 222 2006 46
45. K. Osuka, P.J. Feustel, A.A. Mongin, B.I. Tranmer, and H.K. Kimelberg Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat J Neurochem 76 2001 1842
46. E.M. Rutledge, M. Aschner, and H.K. Kimelberg Pharmacological characterization of swelling-induced D-[3H]aspartate release from primary astrocyte cultures Am J Physiol 274 1998 C1511
47. G. Barreto, M. Santos-Galindo, and Y. Diz-Chaves et al. Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones Endocrinology 150 2009 5010
48. T. Suuronen, T. Nuutinen, J. Huuskonen, J. Ojala, A. Thornell, and A. Salminen Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells Inflamm Res 54 2005 194
49. D. Chesnoy-Marchais The estrogen receptor modulator tamoxifen enhances spontaneous glycinergic synaptic inhibition of hypoglossal motoneurons Endocrinology 146 2005 4302
50. S. Benvenuti, P. Luciani, and G.B. Vannelli et al. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures J Clin Endocrinol Metab 90 2005 1775
51. J.R. Kuo, C.C. Wang, S.K. Huang, and S.J. Wang Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Ca in rat cerebral cortex nerve terminals Neurochem Int 60 2012 105
52. E.H. Pettus, D.W. Wright, D.G. Stein, and S.W. Hoffman Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury Brain Res 1049 2005 112
53. D.W. Wright, A.L. Kellermann, and V.S. Hertzberg et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury Ann Emerg Med 49 2007 391
54. G. Xiao, J. Wei, W. Yan, W. Wang, and Z. Lu Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial Crit Care 12 2008 R61